GlaxoSmithKline (GSK) Reports Q1 EPS of GBP0.20

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. SMCI
8. RTX
9. S
10. COF

Go back to GlaxoSmithKline (GSK) Reports Q1 EPS of GBP0.20

GlaxoSmithKline (GSK) Receives Positive CHMP Opinion on Umbipro as Umbilical Cord Infection Treatment

April 29, 2016 8:23 AM EDT

On 28 April 2016, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion in accordance with Article 58 of Regulation (EC) No 726/20041 for the medicinal product Umbipro, intended for the prophylaxis of omphalitis (infection of the umbilical cord) in newborn infants. This medicinal product has been developed by GlaxoSmithKline... More